A Study of the Longitudinal Patterns of Stimulant and Amyl Nitrite Use and Sexual Behavior Pre- and Post-HIV Seroconversion Among MSM.

James A Swartz, David McCarty-Caplan
Author Information
  1. James A Swartz: Jane Addams College of Social Work, University of Illinois at Chicago, 1040 W. Harrison Street, (M/C 309), Chicago, IL, 60607, USA. jaswartz@uic.edu. ORCID
  2. David McCarty-Caplan: Department of Social Work, California State University, Northridge, CA, USA.

Abstract

The use of stimulant drugs alone or in combination with amyl nitrites (stimulant/nitrites) has been associated with higher rates of risky sexual behavior and predictive of HIV infection among men who have sex with men. However, the temporal pattern of stimulant/Nitrite use pre- and post-seroconversion has not been well established. This study assessed changes in stimulant/Nitrite use and risky sexual behavior among seroconverting MSM over time. Data were collected in the Baltimore-Washington, DC; Pittsburgh; Chicago; and Los Angeles sites of the Multicenter AIDS Cohort Study (MACS), a longitudinal study of the natural history of HIV infection among MSM. We used propensity scores to select 1044 MSM from 7087 MACS participants composed of 348 seroconverting, 348 seronegative, and 348 seroprevalent participants matched on demographics, recruitment cohort, and study visits. We centered up to four-years of semi-annual data around the seroconversion visit of the seroconverting case within each matched group of participants. Mixed effects regressions estimated the effects of serostatus, recruitment cohort, and time on self-reported stimulant/Nitrite use, numbers of male intercourse partners, and numbers of unprotected receptive anal intercourse (URAI) partners. Covariates included demographics, binge drinking, and marijuana use. Seroconverters had the highest odds of stimulant/inhaled Nitrite use (AOR 10.3, CI 4.8-22.0), incident rates of intercourse (IRR 1.6, CI 1.3-2.1), and URAI partners (IRR 5.1, CI 3.5-7.3). All participants decreased drug use and sexual risk behavior over time. However, the decreases were largest for seroconverters who nevertheless maintained the highest rates of stimulant/Nitrite use and sexual risk. Cohort-related effects were associated with sharp reductions in stimulant/Nitrite use and URAI in the early 1990s that rebounded considerably within the first decade of the 2000s. Although all participants decreased risky sexual behavior and stimulant and/or Nitrite use over time, seroconverters had the largest decreases. There was no evidence for abrupt or substantial increases in drug use or risky sex post-seroconversion. However, there was substantial variation at the individual level, with the factors underlying this variation not well understood and worth further study. Moreover, stimulant/Nitrite use and risky sexual behavior appear to have been strongly influenced by contextual historical and socio-cultural effects. The manner in which contextual factors influence individual behavior is also not well understood and also warrants further study.

Keywords

References

  1. Curr HIV/AIDS Rep. 2005 Nov;2(4):194-9 [PMID: 16343378]
  2. AIDS Behav. 2009 Aug;13(4):757-82 [PMID: 18236149]
  3. Sex Transm Dis. 2009 Nov;36(11):693-5 [PMID: 19704399]
  4. AIDS Behav. 2016 Mar;20(3):646-54 [PMID: 26139422]
  5. Am J Epidemiol. 1987 Aug;126(2):310-8 [PMID: 3300281]
  6. J Acquir Immune Defic Syndr. 2009 Jul 1;51(3):349-55 [PMID: 19387357]
  7. J Urban Health. 2005 Mar;82(1 Suppl 1):i120-6 [PMID: 15738313]
  8. Pharm Stat. 2011 Mar-Apr;10(2):150-61 [PMID: 20925139]
  9. J Infect Dis. 2003 Dec 15;188(12):1820-6 [PMID: 14673760]
  10. J Urban Health. 2006 Nov;83(6):1151-7 [PMID: 17111217]
  11. AIDS Care. 2003 Dec;15(6):775-85 [PMID: 14617499]
  12. AIDS Behav. 2015 Mar;19(3):422-30 [PMID: 25194967]
  13. AIDS. 2013 Mar 13;27(5):815-23 [PMID: 23719351]
  14. AIDS Behav. 2015 Jun;19(6):970-80 [PMID: 25192900]
  15. AIDS Behav. 2014 Jul;18(7):1339-51 [PMID: 24065437]
  16. Lancet. 2010 Aug 7;376(9739):398-400 [PMID: 20650516]
  17. Subst Abus. 2010 Oct;31(4):224-30 [PMID: 21038176]
  18. J Health Psychol. 2016 Jan;21(1):93-9 [PMID: 24578373]
  19. J Assoc Nurses AIDS Care. 2009 Jan-Feb;20(1):31-8 [PMID: 19118769]
  20. Subst Use Misuse. 2011;46(2-3):264-73 [PMID: 21303246]
  21. Addict Behav. 2008 Aug;33(8):1055-60 [PMID: 18430520]
  22. J Urban Health. 2005 Mar;82(1 Suppl 1):i62-70 [PMID: 15738319]
  23. J Addict Dis. 2002;21(1):91-105 [PMID: 11831503]
  24. Drug Alcohol Depend. 2013 Nov 1;133(1):262-5 [PMID: 23890490]
  25. Am J Addict. 2009 Jan-Feb;18(1):65-72 [PMID: 19219667]
  26. Ann Epidemiol. 2008 Oct;18(10):752-9 [PMID: 18693041]
  27. J Acquir Immune Defic Syndr. 2007 May 1;45(1):85-92 [PMID: 17325605]
  28. Addiction. 2008 Apr;103(4):546-56 [PMID: 18339100]
  29. EMBO Rep. 2012 Nov 6;13(11):948-53 [PMID: 23070365]
  30. Arch Sex Behav. 2011 Apr;40(2):273-9 [PMID: 19330436]
  31. Arch Pediatr Adolesc Med. 2007 Jun;161(6):591-6 [PMID: 17548765]
  32. AIDS Behav. 2012 Jan;16(1):151-8 [PMID: 21191644]
  33. AIDS. 1993 Jan;7(1):1-13 [PMID: 8095144]
  34. J Homosex. 2001;41(2):17-35 [PMID: 11482426]
  35. J Acquir Immune Defic Syndr. 2011 Feb 1;56(2):176-82 [PMID: 21119524]
  36. AIDS Educ Prev. 2010 Apr;22(2):126-37 [PMID: 20387983]
  37. Curr Opin Infect Dis. 2016 Feb;29(1):58-63 [PMID: 26694620]
  38. Sex Transm Dis. 2009 Sep;36(9):547-55 [PMID: 19707108]
  39. AIDS. 2002 Mar 29;16(5):775-80 [PMID: 11964534]
  40. J Psychoactive Drugs. 2003 May;35 Suppl 1:161-8 [PMID: 12825759]
  41. Annu Rev Public Health. 2010;31:385-98 [PMID: 20070191]
  42. Int J Epidemiol. 2015 Oct;44(5):1506-16 [PMID: 24771276]
  43. Curr Opin Infect Dis. 2010 Feb;23(1):53-6 [PMID: 19918176]
  44. Am J Drug Alcohol Abuse. 2016 Mar;42(2):168-77 [PMID: 26837461]
  45. Int J Drug Policy. 2016 Oct;36:148-50 [PMID: 26874991]
  46. Sex Transm Infect. 2008 Nov;84(6):509-11 [PMID: 19028957]
  47. Am J Public Health. 2010 Oct;100(10):1892-5 [PMID: 20724693]
  48. Drug Alcohol Depend. 2010 Mar 1;107(2-3):119-27 [PMID: 19939585]
  49. Addiction. 2007 Apr;102 Suppl 1:130-5 [PMID: 17493062]

Grants

  1. U01 AI035042/NIAID NIH HHS
  2. R03 DA025985/NIDA NIH HHS
  3. UL1 TR001079/NCATS NIH HHS
  4. U01 AI035041/NIAID NIH HHS
  5. UM1 AI035043/NIAID NIH HHS
  6. U01 AI035040/NIAID NIH HHS
  7. U01 AI035039/NIAID NIH HHS

MeSH Term

Adult
Amyl Nitrite
Central Nervous System Stimulants
Cohort Studies
HIV Infections
HIV Seronegativity
HIV Seropositivity
HIV-1
Homosexuality, Male
Humans
Longitudinal Studies
Male
Risk Reduction Behavior
Risk-Taking
Seroconversion
Sexual Behavior
Sexual Partners
Young Adult

Chemicals

Central Nervous System Stimulants
Amyl Nitrite

Word Cloud

Created with Highcharts 10.0.0usesexualbehaviorstimulant/nitritestudyriskyMSMparticipantstimeeffects1ratesHIVamongHoweverwellseroconvertingStudyMACS348intercoursepartnersURAI3CIstimulantnitritesassociatedinfectionmensexpost-seroconversionAIDSCohortmatcheddemographicsrecruitmentcohortwithinnumbershighestnitriteIRRdecreaseddrugriskdecreaseslargestseroconverterssubstantialvariationindividualfactorsunderstoodcontextualalsoLongitudinalStimulantAmyldrugsalonecombinationamylstimulant/nitriteshigherpredictivetemporalpatternpre-establishedassessedchangesDatacollectedBaltimore-WashingtonDCPittsburghChicagoLosAngelessitesMulticenterlongitudinalnaturalhistoryusedpropensityscoresselect10447087composedseronegativeseroprevalentvisitscenteredfour-yearssemi-annualdataaroundseroconversionvisitcasegroupMixedregressionsestimatedserostatusself-reportedmaleunprotectedreceptiveanalCovariatesincludedbingedrinkingmarijuanaSeroconvertersoddsstimulant/inhaledAOR1048-220incident63-255-7neverthelessmaintainedCohort-relatedsharpreductionsearly1990sreboundedconsiderablyfirstdecade2000sAlthoughand/orevidenceabruptincreaseslevelunderlyingworthMoreoverappearstronglyinfluencedhistoricalsocio-culturalmannerinfluencewarrantsPatternsNitriteUseSexualBehaviorPre-Post-HIVSeroconversionAmongMulti-sitePoppers

Similar Articles

Cited By (9)